Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model
Mary Y. Heng, … , Louis J. Ptáček, Ying-Hui Fu
Mary Y. Heng, … , Louis J. Ptáček, Ying-Hui Fu
Published May 15, 2013
Citation Information: J Clin Invest. 2013;123(6):2719-2729. https://doi.org/10.1172/JCI66737.
View: Text | PDF
Research Article Neuroscience

Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model

  • Text
  • PDF
Abstract

Adult-onset autosomal-dominant leukodystrophy (ADLD) is a progressive and fatal neurological disorder characterized by early autonomic dysfunction, cognitive impairment, pyramidal tract and cerebellar dysfunction, and white matter loss in the central nervous system. ADLD is caused by duplication of the LMNB1 gene, which results in increased lamin B1 transcripts and protein expression. How duplication of LMNB1 leads to myelin defects is unknown. To address this question, we developed a mouse model of ADLD that overexpresses lamin B1. These mice exhibited cognitive impairment and epilepsy, followed by age-dependent motor deficits. Selective overexpression of lamin B1 in oligodendrocytes also resulted in marked motor deficits and myelin defects, suggesting these deficits are cell autonomous. Proteomic and genome-wide transcriptome studies indicated that lamin B1 overexpression is associated with downregulation of proteolipid protein, a highly abundant myelin sheath component that was previously linked to another myelin-related disorder, Pelizaeus-Merzbacher disease. Furthermore, we found that lamin B1 overexpression leads to reduced occupancy of Yin Yang 1 transcription factor at the promoter region of proteolipid protein. These studies identify a mechanism by which lamin B1 overexpression mediates oligodendrocyte cell–autonomous neuropathology in ADLD and implicate lamin B1 as an important regulator of myelin formation and maintenance during aging.

Authors

Mary Y. Heng, Shu-Ting Lin, Laure Verret, Yong Huang, Sherry Kamiya, Quasar S. Padiath, Ying Tong, Jorge J. Palop, Eric J. Huang, Louis J. Ptáček, Ying-Hui Fu

×

Figure 5

Lamin B1 overexpression in oligodendrocytes results in progressive motor impairment and myelin deficits.

Options: View larger image (or click on image) Download as PowerPoint
Lamin B1 overexpression in oligodendrocytes results in progressive motor...
(A) Representative Western blot for lamin B1, FLAG-tagged lamin B1, and α-tubulin in hemibrain lysates from transgenic mouse lines overexpressing lamin B1 selectively in oligodendrocytes, neurons, and astrocytes driven by cell-type–specific promoters (Plp1, Camk2a, and GFAP, respectively) vs. control mice at 12 months of age (lanes are discontinuous). Dual color detection with IR fluorescence for antibody against lamin B1 (green) and antibody against FLAG-tagged lamin B1 (red; top panel). Individual detection against FLAG (second panel), lamin B1 (third panel), and α-tubulin (bottom panel). (B) Quantification of Western blots of total lamin B1 normalized to α-tubulin. (C) qRT-PCR of lamin B1 transcript levels normalized to GAPDH from corresponding cell-specific hemibrains at 12 months of age. Error bars represent mean ± SEM from 3–4 independent experiments. (D–F) Animals overexpressing lamin B1 selectively in oligodendrocytes (PLP-LMNB1Tg) exhibited progressive motor deficits on the accelerated rotarod and balance beam. (D) PLP-LMNB1Tg mice had shortened latency to fall on the accelerated rotarod and (E) exhibited increased latency to traverse an 11-mm–wide balance beam with (F) hind limb slips. Values are expressed as means ± SEM, n = 10–12 per group. ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts